T. Levy et al., Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation, AM J CARD, 84(4), 1999, pp. 426-429
Citations number
11
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
It has been suggested biatrial pacing may prevent the recurrence of atrial
fibrillation (AF), To further evaluate this hypothesis, we performed a rand
omized, single-blinded study in 19 patients with drug refractory AF, The st
udy compared biatrial pacing with conventional right atrial (RA) pacing and
a control period of inhibited pacing, The pacing modes utilized were DDD w
ith a base rate of 70 beats/min for biatrial and RA pace (with and without
biatrial resynchronization, respectively) and 40 beats/min for the control
period. The duration of each pacing mode was 3 months. The number of AF epi
sodes and their duration were obtained from pacemaker Holter memory (Chorus
RM ELA Medical). Comparison of the control period (n = 11) with either pac
ing strategy showed a significant decrease in the total duration of AF (con
trol 27 +/- 35 days, biatrial 8 +/- 15 days p = 0.02, RA 11 +/- 27 days p =
0.04), However, there was no effect on the number of AF episodes (control
79 +/- 108, biatrial 36 +/- 75 p = 0.32, RA 41 +/- 80 p = 0,11), The total
percentage of atrial pacing also significantly increased when the control p
eriod (6 +/- 9%) was compared with both RA pace (62 +/- 33%, p = 0.008) and
biatrial pace (63 +/- 31, p = 0.003), When biatrial pacing was compared wi
th RA pace (n = 19), there was no significant difference in either the dura
tion of AF (biatrial 16 +/- 26 days vs RA 19 +/- 31 days, p = 0.7) or the n
umber of AF episodes (biatrial 56 +/- 91 vs RA 87 +/- 106, p = 0.34), In co
nclusion, pacing (either type) at a base rate of 70 beats/min has an antifi
brillatory effect when compared with inhibited pacing at 40 beats/min. No a
dditional benefit of biatrial pacing over right atrial pacing was demonstra
ted in this study, (C) 1999 by Excerpta Medica, Inc.